Law360, New York (June 10, 2010, 3:11 PM ET) -- Pfizer Inc. has confirmed that it received a warning from the U.S. Food and Drug Administration for not reporting post-marketing side effects from its drugs in a timely fashion.
The pharmaceutical giant acknowledged Wednesday that it had received the warning June 3 related to an FDA inspection that ended in August 2009.
A Pfizer spokeswoman confirmed that the drugmaker had forwarded a copy of the FDA letter to Reuters but did not immediately provide the warning to Law360 on Thursday.
The FDA's 12-page letter related to...
FDA Rebukes Pfizer Over Late Reports Of Side Effects
To view the full article, take a free trial now.
